Immunotherapies could target aggressive pancreatic cancer, research indicates
The Pharma Data
SEPTEMBER 3, 2020
The research, published in the journal Gut, revealed that 83% of aggressive, metastatic-like tumours contained particularly high levels of a gene called TLR3, part of a damage-alert system that mimics the infection response triggered by viruses, drawing immune cells to the tumour.
52 
Let's personalize your content